Home - Products - Others - Other Targets - LDC-4297 HCl (1453834-21-3(free base))

LDC-4297 HCl (1453834-21-3(free base))

CAS No.

LDC-4297 HCl (1453834-21-3(free base)) ( —— )

Catalog No. M17706 CAS No.

LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 101 Get Quote
10MG 172 Get Quote
25MG 354 Get Quote
50MG 647 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LDC-4297 HCl (1453834-21-3(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM.
  • Description
    LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CDK7
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    469.02
  • Molecular Formula
    C23H29ClN8O
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    Cl.CC(C)c1cnn2c(nc(nc12)OC3CCCNC3)NCc5ccccc5n4cccn4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hutterer C,etal. 2015 Apr;59(4):2062-71.
molnova catalog
related products
  • Somatostatin

    Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and glucagon, and is also generated in the hypothalamus, where it inhibits the release of growth hormone and thyroid-stimulating hormones from the anterior pituitary.Somatostatin is a tetradecapeptide which can suppress the growth hormone (GH) secretion and control the pituitary hormone secretion in human CNS.

  • Licarbazepine

    Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.

  • Saponarin

    Saponarin shows in vitro and in vivo hepatoprotective and antioxidant activity against CCl4-induced liver damage.